Comparative effectiveness of budesonide EC and telitacicept in proteinuria and eGFR trajectories in IgA nephropathy: a retrospective cohort study.

Front Immunol · 2026 · PMC13212180 · PMID 42212126

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a possible trendno p-value reported

Conclusions The relative antiproteinuric effect of telitacicept versus budesonide EC may be modified by baseline proteinuria, with a possible trend toward greater benefit in patients with mild-to-moderate levels.

also in 939 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.